✦ 24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Loading

Fetching the latest headlines…

NabkaNews aggregates headlines from thousands of publishers worldwide via Google News, and provides AI-generated summaries and briefings for convenience. Every story links to its original source. We do not host or claim ownership of third-party reporting, and AI summaries may contain errors — always verify with the original source.

24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Disclaimer Privacy Policy Terms of Use

© 2026 NabkaNews · World · U.S. · India — updated continuously. NabkaNews is an independent news aggregator and is not affiliated with any publisher shown.

New ALS drug neflamapimod chosen for UK platform study · NabkaNews

← Back to headlines

New ALS drug neflamapimod chosen for UK platform study

ALS News Today·Feb 20

This story is reported by ALS News Today. Read what other outlets are saying below, then open the original report for full details.

Full coverage

AB Science adds new biomarker to Phase 3 masitinib ALS clinical trial

ALS News Today·Mar 2

Experimental oral therapy SPG302 may slow ALS progression

ALS News Today·Nov 7

Repurposed vet drug helps ALS patients live longer: Study

ALS News Today·Aug 26

Repurposed drugs fail to slow disease progression in ALS trial

ALS News Today·Oct 24

Dazucorilant significantly extends survival in Phase 2 ALS trial

ALS News Today·Jun 16

DNL343, fosigotifator fail HEALEY platform trial’s main goal in ALS

ALS News Today·Jan 9

Neuvivo requests FDA approval of ALS treatment NP001

ALS News Today·Oct 9

Radicava delays time to certain ALS disease progression milestones

ALS News Today·Feb 3

View original report at ALS News Today ↗